GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Sito Bio-technology Co Ltd (SZSE:300583) » Definitions » Retained Earnings

Shandong Sito Bio-technology Co (SZSE:300583) Retained Earnings : ¥251.2 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Shandong Sito Bio-technology Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Shandong Sito Bio-technology Co's retained earnings for the quarter that ended in Mar. 2025 was ¥251.2 Mil.

Shandong Sito Bio-technology Co's quarterly retained earnings declined from Sep. 2024 (¥382.2 Mil) to Dec. 2024 (¥278.7 Mil) and declined from Dec. 2024 (¥278.7 Mil) to Mar. 2025 (¥251.2 Mil).

Shandong Sito Bio-technology Co's annual retained earnings increased from Dec. 2022 (¥415.0 Mil) to Dec. 2023 (¥452.8 Mil) but then declined from Dec. 2023 (¥452.8 Mil) to Dec. 2024 (¥278.7 Mil).


Shandong Sito Bio-technology Co Retained Earnings Historical Data

The historical data trend for Shandong Sito Bio-technology Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Sito Bio-technology Co Retained Earnings Chart

Shandong Sito Bio-technology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 350.46 374.59 415.04 452.83 278.70

Shandong Sito Bio-technology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 455.90 380.67 382.18 278.70 251.19

Shandong Sito Bio-technology Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Shandong Sito Bio-technology Co  (SZSE:300583) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Shandong Sito Bio-technology Co Business Description

Traded in Other Exchanges
N/A
Address
South Section of East Outer Ring Road, Dingtao District, Shandong Province, Heze, CHN, 274100
Shandong Sito Bio-technology Co Ltd is a biotechnology company. It uses genetic engineering technology and microbial transformation technology to develop and produce steroid drug raw materials, specialty respiratory raw materials and finished preparations, and other drug intermediaries. The company operates in the following business segments; intermediates, high-end specialty respiratory APIs, and preparations. Its product offerings include androstenedione (AD), 9-hydroxy androstenedione (90H-AD), 17a-hydroxyprogesterone derivatives (A ring), and bi-decanoic acid (BA), and others. In addition, the company holds patents for various APIs and other intermediaries.
Executives
Mi Qi Directors, executives
Wang Min Director
Kong Qing Zhi Executives
He Jian Yong Directors, executives
Ceng Qing Li Securities Affairs Representative

Shandong Sito Bio-technology Co Headlines

No Headlines